Consensus-based care recommendations for adults with myotonic dystrophy type 1

…, C Campbell, E Cup, JW Day, E De Mattia… - Neurology: Clinical …, 2018 - AAN Enterprises
Purpose of review Myotonic dystrophy type 1 (DM1) is a severe, progressive genetic
disease that affects between 1 in 3,000 and 8,000 individuals globally. No evidence-based …

Consensus-based care recommendations for pulmonologists treating adults with myotonic dystrophy type 1

M Boentert, M Cao, D Mass, E De Mattia, E Falcier… - Respiration, 2020 - karger.com
Purpose of Review: Myotonic dystrophy type 1 (DM1) is a severe, progressive genetic
disease that affects approximately 1 in 2,500 individuals globally [Ashizawa et al.: Neurol Clin …

Weaning from tracheotomy in long-term mechanically ventilated patients: feasibility of a decisional flowchart and clinical outcome

…, M Delmastro, GC Piaggi, E De Mattia… - Intensive care …, 2003 - Springer
Objective To assess the feasibility of following a decisional flowchart to decide whether to
remove tracheotomy in long-term mechanically ventilated patients. Design and setting …

Genetic modifiers of respiratory function in Duchenne muscular dystrophy

…, G Baranello, E Albamonte, E De Mattia… - Annals of clinical …, 2020 - Wiley Online Library
Objective Respiratory insufficiency is a major complication of Duchenne muscular dystrophy
(DMD). Its progression shows considerable interindividual variability, which has been less …

Expanded access program with Nusinersen in SMA type I in Italy: strengths and pitfalls of a successful experience

…, A Pirola, S Luppone, E De Mattia… - Neuromuscular …, 2017 - nmd-journal.com
We would like to share our experience with the expanded access program (EAP) using
Nusinersen in infants and children with type 1 Spinal muscular atrophy (SMA). EAP is the use of …

The prognostic value of spirometric tests in amyotrophic lateral sclerosis patients

A Pirola, E De Mattia, A Lizio, G Sannicolò… - Clinical neurology and …, 2019 - Elsevier
Objective Amyotrophic lateral sclerosis (ALS) patients tend to develop progressive respiratory
muscle weakness, leading to ventilatory failure and ineffective cough, principal causes of …

[HTML][HTML] Physiological response to intrapulmonary percussive ventilation in stable COPD patients

S Nava, N Barbarito, G Piaggi, E De Mattia, S Cirio - Respiratory medicine, 2006 - Elsevier
Intrapulmonary percussive ventilation (IPV) is a ventilatory technique that delivers bursts of
high-flow respiratory gas into the lung at high rates, intended for treating acute respiratory …

Screening for early symptoms of respiratory involvement in myotonic dystrophy type 1 using the Respicheck questionnaire

E De Mattia, A Lizio, E Falcier, G Sannicolò… - Neuromuscular …, 2020 - Elsevier
Symptoms of respiratory involvement are frequently present but overlooked by patients with
Myotonic Dystrophy type 1 (DM1). A respiratory symptom checklist was designed to test …

[HTML][HTML] Assessment of respiratory function and need for noninvasive ventilation in a cohort of patients with myotonic dystrophy type 1 followed at one single expert …

…, F Rao, E Roma, A Iannello, E De Mattia… - Canadian Respiratory …, 2022 - hindawi.com
Introduction. Respiratory insufficiency is one of the main causes of death in myotonic dystrophy
type 1 (DM1). Although there is general consensus that these patients have a restrictive …

Passive versus active circuit during invasive mechanical ventilation in subjects with amyotrophic lateral sclerosis

E De Mattia, E Falcier, A Lizio, C Lunetta… - Respiratory …, 2018 - rc.rcjournal.com
BACKGROUND: Until recently, it has been considered essential to maintain the use of a
double-limb circuit in patients with amyotrophic lateral sclerosis (ALS) to avoid rebreathing …